E. Orlandi et al., SECONDARY ACUTE MYELOID-LEUKEMIA FOLLOWING TREATMENT WITH VP16-CONTAINING REGIMENS FOR NON-HODGKINS-LYMPHOMA, Haematologica, 83(8), 1998, pp. 758-759
We report on two patients who developed a secondary acute myeloid leuk
emia (sAL) after treatment for non-Hodgkin's lymphoma (NHL) with regim
ens containing low to intermediate doses of VP16. Clinical and hematol
ogic features in these two patients were consistent with epipodophyllo
toxin-associated sAL. In one case, a rearrangement of chromosome band
11q23 was detected.